UnknownNot Applicable

Bilateral Serratus Intercostal Plane Block for Myocardial Revascularization (SERRINT)

Colombia44 participantsStarted 2019-01-15

Plain-language summary

Two-parallel arm, double-blind, individually randomized controlled trial. Primary endpoint: Fentanyl consumption in the first 48 postoperative hours. Secondary endpoints: Pain at rest, Pain on movement, stay in ICU, Postoperative nausea and vomiting (PONV), sedation, Hemothorax, seizures, arrythmias

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient between 18 years to 80 years * Patient to myocardial revascularization by sternotomy Exclusion Criteria: * Patient for combined surgery ( myocardial revascularization by sternotomy plus valve or maze) * Emergency surgery * Ejection Fraction less than 35% * Allergy to the local anesthesics. * Allergy to opioids * Patient in who will be technically impossible the application of the blockade

What they're measuring

Fentanyl Consume

Timeframe: 48 hours

Trial details

NCT IDNCT03813225

SponsorFundación Cardiovascular de Colombia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-30

Contact for this trial

Luz Pacheco, Esp

57 7 6396767 luzjepal@gmail.com

View on ClinicalTrials.gov More Pain, Postoperative trials